Accordingly, gene expression, Western blot and ELISA analyses (Fig. 1H) showed higher PTX3 expression and secretion in TNBC cell lines when compared to ER+/PR+ and HER2+ breast cancer cells. This evidence concerns the gene PTX3 and breast carcinoma.